One of the best characterized mutations in humans is the substitution K388R that blocks ATP binding and hydrolysis, and that represents a pathogenic form of Spastin since it has been found in HSP patients (Fonknechten et al., 2000; Errico et al., 2002). This evidence concerns the gene SPAST and hereditary spastic paraplegia.